Extensive use of vasodilator agents and functional echocardiography to monitor extremely-low-birth-weight infants in Japan
Autor: | Masafumi Miyata, M. Murase, M. Kotani, K. Toyoshima, H. Kawato, K. Tanaka, M. Kobayashi, K. Yamamoto, Hitoshi Yoda |
---|---|
Rok vydání: | 2016 |
Předmět: |
medicine.medical_specialty
Cardiotonic Agents Dopamine Vasodilator Agents Blood Pressure Ventricular Function Left 03 medical and health sciences Wall stress 0302 clinical medicine Japan Afterload 030225 pediatrics Internal medicine medicine Humans 030212 general & internal medicine Practice Patterns Physicians' Monitoring Physiologic business.industry Infant Newborn Prognosis Left ventricular contractility Myocardial Contraction Low birth weight medicine.anatomical_structure Echocardiography Infant Extremely Low Birth Weight Ventricle Vasodilator agents Health Care Surveys Pediatrics Perinatology and Child Health Circulatory system Cardiovascular agent Cardiology medicine.symptom business Infant Premature |
Zdroj: | Journal of Neonatal-Perinatal Medicine. 9:261-269 |
ISSN: | 1878-4429 1934-5798 |
DOI: | 10.3233/npm-16915113 |
Popis: | National surveys were conducted in Japan to assess the current practices for circulatory management of extremely-low-birth-weight infants (ELBWIs) in acute phases. Approximately 80 and 100 institutions were surveyed in 2006 and 2011, respectively. Echocardiography was identified as an important diagnostic tool at 95% of the surveyed institutions. Furthermore, 74% of the institutions survey in 2011 used vasodilator agents. In 2011, the mean velocity of circumferential fiber shortening (mVcfc) and left ventricular end-systolic wall stress (ESWS) were used by 60% of the surveyed institutions to evaluate the relationship between afterload of the left ventricle and left ventricular contractility. Overall, the data collected from these national surveys clarified the current practices for circulatory management of ELBWIs in Japan, particularly the use of echocardiography and cardiovascular agents, including catecholamines and vasodilators. |
Databáze: | OpenAIRE |
Externí odkaz: |